questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Utilisations thérapeutiques
Agents régulateurs de la reproduction
Fécondostimulants
Fécondostimulants : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fécondostimulants : Questions médicales les plus fréquentes",
"headline": "Fécondostimulants : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fécondostimulants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-30",
"dateModified": "2025-02-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fécondostimulants"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Agents régulateurs de la reproduction",
"url": "https://questionsmedicales.fr/mesh/D012102",
"about": {
"@type": "MedicalCondition",
"name": "Agents régulateurs de la reproduction",
"code": {
"@type": "MedicalCode",
"code": "D012102",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fécondostimulants féminins",
"alternateName": "Fertility Agents, Female",
"url": "https://questionsmedicales.fr/mesh/D005300",
"about": {
"@type": "MedicalCondition",
"name": "Fécondostimulants féminins",
"code": {
"@type": "MedicalCode",
"code": "D005300",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.552.344"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fécondostimulants masculins",
"alternateName": "Fertility Agents, Male",
"url": "https://questionsmedicales.fr/mesh/D005303",
"about": {
"@type": "MedicalCondition",
"name": "Fécondostimulants masculins",
"code": {
"@type": "MedicalCode",
"code": "D005303",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.552.510"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Fécondostimulants",
"alternateName": "Fertility Agents",
"code": {
"@type": "MedicalCode",
"code": "D005299",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "N Chabbert-Buffet",
"url": "https://questionsmedicales.fr/author/N%20Chabbert-Buffet",
"affiliation": {
"@type": "Organization",
"name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France. Electronic address: nathalie.chabbert-buffet@aphp.fr."
}
},
{
"@type": "Person",
"name": "N Sermondade",
"url": "https://questionsmedicales.fr/author/N%20Sermondade",
"affiliation": {
"@type": "Organization",
"name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France."
}
},
{
"@type": "Person",
"name": "E Moreau",
"url": "https://questionsmedicales.fr/author/E%20Moreau",
"affiliation": {
"@type": "Organization",
"name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France."
}
},
{
"@type": "Person",
"name": "S Cristofari",
"url": "https://questionsmedicales.fr/author/S%20Cristofari",
"affiliation": {
"@type": "Organization",
"name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France."
}
},
{
"@type": "Person",
"name": "N Johnson",
"url": "https://questionsmedicales.fr/author/N%20Johnson",
"affiliation": {
"@type": "Organization",
"name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis.",
"datePublished": "2023-08-14",
"url": "https://questionsmedicales.fr/article/37586673",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clim.2023.109740"
}
},
{
"@type": "ScholarlyArticle",
"name": "Elevated interleukin-11 in systemic sclerosis and role in disease pathogenesis.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37291792",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1346-8138.16854"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis.",
"datePublished": "2023-05-20",
"url": "https://questionsmedicales.fr/article/37210571",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13075-023-03063-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence and clinical association of sarcopenia among Thai patients with systemic sclerosis.",
"datePublished": "2022-10-28",
"url": "https://questionsmedicales.fr/article/36307496",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-21914-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development and validation of machine learning for early mortality in systemic sclerosis.",
"datePublished": "2022-10-13",
"url": "https://questionsmedicales.fr/article/36229500",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-22161-9"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Utilisations thérapeutiques",
"item": "https://questionsmedicales.fr/mesh/D045506"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agents régulateurs de la reproduction",
"item": "https://questionsmedicales.fr/mesh/D012102"
},
{
"@type": "ListItem",
"position": 6,
"name": "Fécondostimulants",
"item": "https://questionsmedicales.fr/mesh/D005299"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fécondostimulants - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fécondostimulants",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fécondostimulants",
"description": "Comment diagnostiquer l'infertilité ?\nQuels tests pour évaluer la réserve ovarienne ?\nQuand consulter un spécialiste de la fertilité ?\nQuels signes indiquent un problème d'ovulation ?\nComment évaluer la qualité du sperme ?",
"url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Scleroderma,+Diffuse&page=6#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fécondostimulants",
"description": "Quels symptômes d'infertilité chez la femme ?\nQuels signes d'infertilité chez l'homme ?\nComment reconnaître un déséquilibre hormonal ?\nQuels symptômes d'ovulation irrégulière ?\nQuels symptômes d'une maladie des ovaires ?",
"url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Scleroderma,+Diffuse&page=6#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fécondostimulants",
"description": "Comment prévenir l'infertilité ?\nQuel rôle de l'alimentation sur la fertilité ?\nComment le stress affecte-t-il la fertilité ?\nPourquoi éviter les toxines environnementales ?\nQuel impact de l'âge sur la fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Scleroderma,+Diffuse&page=6#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fécondostimulants",
"description": "Quels sont les principaux fécondostimulants ?\nComment fonctionne le clomifène ?\nQuand utiliser des gonadotrophines ?\nQuels effets secondaires des fécondostimulants ?\nComment se déroule une stimulation ovarienne ?",
"url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Scleroderma,+Diffuse&page=6#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fécondostimulants",
"description": "Quelles complications des fécondostimulants ?\nComment reconnaître le syndrome d'hyperstimulation ?\nQuels risques de grossesses multiples ?\nQuelles sont les conséquences d'une grossesse multiple ?\nQuels effets à long terme des fécondostimulants ?",
"url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Scleroderma,+Diffuse&page=6#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fécondostimulants",
"description": "Quels facteurs de risque d'infertilité ?\nQuel impact des antécédents familiaux ?\nComment le poids influence-t-il la fertilité ?\nQuel rôle des maladies chroniques ?\nComment l'environnement influence-t-il la fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Scleroderma,+Diffuse&page=6#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'infertilité ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'infertilité se diagnostique par des tests hormonaux, échographies et analyses de sperme."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer la réserve ovarienne ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par la mesure de l'hormone antimüllérienne (AMH) et l'échographie."
}
},
{
"@type": "Question",
"name": "Quand consulter un spécialiste de la fertilité ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter après un an d'essais infructueux pour les couples de moins de 35 ans."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un problème d'ovulation ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cycles irréguliers, des règles absentes ou des douleurs pelviennes peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Comment évaluer la qualité du sperme ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La qualité du sperme est évaluée par une analyse de sperme, mesurant la concentration et la motilité."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'infertilité chez la femme ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des cycles irréguliers, des douleurs pelviennes et des règles absentes."
}
},
{
"@type": "Question",
"name": "Quels signes d'infertilité chez l'homme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes peuvent inclure des problèmes d'érection, des douleurs testiculaires ou des anomalies du sperme."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un déséquilibre hormonal ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'acné, la prise de poids ou des changements d'humeur peuvent indiquer un déséquilibre."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'ovulation irrégulière ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cycles menstruels irréguliers et des douleurs pelviennes peuvent signaler une ovulation irrégulière."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une maladie des ovaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs pelviennes, des règles irrégulières et des problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infertilité ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un poids santé, éviter le tabac et gérer le stress peuvent aider à prévenir l'infertilité."
}
},
{
"@type": "Question",
"name": "Quel rôle de l'alimentation sur la fertilité ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en antioxydants et en acides gras oméga-3 peut améliorer la fertilité."
}
},
{
"@type": "Question",
"name": "Comment le stress affecte-t-il la fertilité ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut perturber les cycles hormonaux et affecter l'ovulation, réduisant ainsi la fertilité."
}
},
{
"@type": "Question",
"name": "Pourquoi éviter les toxines environnementales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les toxines peuvent nuire à la qualité du sperme et à la santé reproductive, augmentant le risque d'infertilité."
}
},
{
"@type": "Question",
"name": "Quel impact de l'âge sur la fertilité ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé réduit la qualité des ovules et la fertilité, surtout après 35 ans chez les femmes."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux fécondostimulants ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux fécondostimulants incluent le clomifène, les gonadotrophines et l'acide folique."
}
},
{
"@type": "Question",
"name": "Comment fonctionne le clomifène ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le clomifène stimule l'ovulation en bloquant les récepteurs d'œstrogènes dans l'hypothalamus."
}
},
{
"@type": "Question",
"name": "Quand utiliser des gonadotrophines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les gonadotrophines sont utilisées lorsque le clomifène est inefficace ou en cas d'infertilité sévère."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des fécondostimulants ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des bouffées de chaleur, des nausées et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment se déroule une stimulation ovarienne ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La stimulation ovarienne implique des injections de médicaments et un suivi échographique régulier."
}
},
{
"@type": "Question",
"name": "Quelles complications des fécondostimulants ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure le syndrome d'hyperstimulation ovarienne et des grossesses multiples."
}
},
{
"@type": "Question",
"name": "Comment reconnaître le syndrome d'hyperstimulation ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des nausées et un gain de poids rapide après traitement."
}
},
{
"@type": "Question",
"name": "Quels risques de grossesses multiples ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les fécondostimulants augmentent le risque de grossesses multiples, ce qui peut entraîner des complications."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une grossesse multiple ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les grossesses multiples peuvent entraîner des naissances prématurées et des complications pour la mère."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme des fécondostimulants ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme peuvent inclure des risques accrus de cancer ovarien, bien que les données soient limitées."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque d'infertilité ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, des antécédents médicaux, le tabagisme et l'obésité."
}
},
{
"@type": "Question",
"name": "Quel impact des antécédents familiaux ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux d'infertilité peuvent augmenter le risque d'infertilité chez les individus."
}
},
{
"@type": "Question",
"name": "Comment le poids influence-t-il la fertilité ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un poids excessif ou insuffisant peut perturber les cycles hormonaux et affecter la fertilité."
}
},
{
"@type": "Question",
"name": "Quel rôle des maladies chroniques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maladies comme le diabète ou le syndrome des ovaires polykystiques peuvent affecter la fertilité."
}
},
{
"@type": "Question",
"name": "Comment l'environnement influence-t-il la fertilité ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition à des produits chimiques et à des toxines peut nuire à la qualité reproductive."
}
}
]
}
]
}
Anti-fibroblast antibodies (AFA) have been reported in systemic sclerosis (SSc) and are known to promote fibroblast activation. Aim of this study was to characterize the fine specificity of AFA and to...
Systemic sclerosis (SSc) is an autoimmune connective tissue disease in which there is elevated inflammation, aberrant cytokine expression, and subsequent fibrosis. Interleukin-11 (IL-11) is a recently...
Systemic sclerosis (SSc) is a multi-organ disease with impaired health-related quality of life (HRQoL). The EULAR SSc Impact of Disease (ScleroID) is a newly introduced SSc-specific patient-reported o...
To investigate the correlation between the ScleroID and the involvement of organ systems as well as disease activity/damage in a SSc cohort from a large tertiary care centre....
The ScleroID and clinical characteristics including internal organ involvement and hand function were investigated in 160 consecutive patients with SSc (median age 46 (43;56) years; diffuse cutaneous ...
A strong correlation was found between the ScleroID and articular disease activity scores (DAS28-CRP, DAS28-ESR, CDAI, SDAI), a hand function performance test, the Hand Anatomy Index and muscle streng...
In a large single-centre cohort, the previously described ScleroID-related findings were confirmed. Furthermore, several organ involvement-related functional and performance tests showed a good correl...
Patients with systemic sclerosis (SSc) have some potential factors associated with an increased risk of sarcopenia. There has been currently no study to examine such associations in SSc patients. We a...
Clinical predictors of mortality in systemic sclerosis (SSc) are diversely reported due to different healthcare conditions and populations. A simple predictive model for early mortality among patients...
Left ventricular diastolic dysfunction (LVDD) remains poorly studied in Systemic Sclerosis (SSc). To determine the prevalence and to define factors associated with LVDD and survival in a large cohort ...
An observational study was conducted with data from the multicentre Spanish Scleroderma Registry (RESCLE) to identify factors associated with LVDD and estimate survival....
Out of 1517 patients, 319 (21.0%) had LVDD. The subset of sine scleroderma SSc was associated to LVDD (14.7% vs. 10.6%, p =0.048), whilst diffuse cutaneous SSc was more prevalent in non-LVDD (16.0 % v...
LVDD is relatively common in SSc patients, and it is associated with worst prognosis, older age, longer time from diagnosis of SSc, presence of telangiectasia and vasodilator treatment....
Dacryoadenitis in the setting of linear scleroderma...
Scleroderma renal crisis is a rare but serious complication of systemic sclerosis. It is usually associated with marked hypertension and carries significant risk for morbidity and mortality. Its occur...
Juvenile localized and systemic scleroderma are rare autoimmune diseases which cause significant disability and morbidity in children. The mechanisms driving juvenile scleroderma remain unclear, neces...
We examined whether an array of scleroderma autoantibodies associates with risk of cancer and could be useful tools for risk stratification....
Scleroderma cancer cases and scleroderma controls without cancer from the Johns Hopkins Scleroderma Center and the University of Pittsburgh Scleroderma Center were studied. Sera were assayed by Linebl...
A total of 676 cases and 687 controls were studied. After adjusting for relevant covariates, anti-POLR3 (odds ratio [OR] 1.47, 95% confidence interval [CI] 1.03-2.11) and monospecific anti-Ro52 (OR 2....
These data suggest that five distinct scleroderma immune responses, alone or in combination, may be useful tools to stratify the risk of cancer for scleroderma patients. Further study examining cancer...